Company / Working Capital per Share
Protagonist Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.37
FY2025
5-year range
$4.32 / $8.37
FY2021-FY2025
Trend
+0.1%
vs FY2024
Sector context
#61 of 210
Health Care
What the data says
At $8.37, Protagonist Therapeutics, Inc.'s working capital per share ranks #61 of 210 in the Health Care sector. Working Capital per Share has increased for 3 consecutive years, from $4.32 in FY2022 to $8.37 in FY2025.
Based on SEC 10-K filings.
8.37 in FY2025 with a 5-year CAGR of +0.9%.
Improved from $5.89 to $8.37 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
#61 of 210 in Health CareTop 29% of 210This company $8.37 Sector average $146.86
▼
-94.3% below sector average
Key checks
Key Insights
- Protagonist Therapeutics, Inc.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 0.1% year-over-year.
- Ranks #61 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.37 | +0.1% |
| FY2024 | $8.36 | +42.0% |
| FY2023 | $5.89 | +36.3% |
| FY2022 | $4.32 | -32.5% |
| FY2021 | $6.41 | -20.0% |
| FY2020 | $8.01 | +88.6% |
| FY2019 | $4.24 | -14.7% |
| FY2018 | $4.98 | -18.7% |
| FY2017 | $6.13 | -48.1% |
| FY2016 | $11.81 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026